How Much Weight Loss Can You Expect from Wegovy?

Last reviewed: July 1, 2026

Last updated: July 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that regulates hunger and blood sugar. Studies demonstrate that patients using this GLP-1 receptor agonist typically lose significantly more weight than those using diet and exercise alone. Understanding realistic outcomes helps you set achievable milestones.

Clinical Trial Data on Semaglutide Weight Loss

The landmark STEP trials followed over 4,500 patients taking semaglutide for 68 weeks. Participants at the highest maintenance dose lost an average of 15-22% of their starting body weight, compared to 2-3% in the placebo group. These results represent among the largest weight reductions ever demonstrated in a non-surgical intervention.

Weight loss typically occurs gradually, with noticeable changes appearing between weeks 8 and 12 of consistent use. Most patients experience their most significant losses during months 3-6, after which the rate of loss often stabilizes. Individual outcomes vary based on adherence, diet quality, physical activity, and genetic factors.

Factors That Influence Your Personal Weight Loss Journey

Baseline body weight significantly affects total pounds lost; patients starting at higher weights often experience larger absolute reductions. Age, metabolic rate, medication compliance, and underlying health conditions all contribute to how your body responds. Diet composition and exercise habits remain crucial—medication amplifies the effect of healthy lifestyle choices rather than replacing them.

The PlexusDx Precision Peptide Genetic Test analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

What Happens During Your First Month of Semaglutide

Initial dosing begins low—typically 0.25 mg weekly—to minimize nausea and allow your system to adapt. Most patients report reduced appetite and food cravings within the first 2-3 weeks, though weight loss may be modest during this baseline phase. This adjustment period is intentional and helps your body establish tolerance.

PlexusDx starts compounded semaglutide at $189 per month, with no flat per-compound pricing changes as your provider increases your dose over time. Your dose may need to go up. Your price won't. This flat-rate model removes financial barriers to finding your optimal therapeutic level, whether you remain at 0.5 mg weekly or advance to higher maintenance doses.

Beyond Weight Loss: Other Health Benefits

Semaglutide improves blood sugar control and reduces insulin resistance, benefiting patients with prediabetes or type 2 diabetes independent of weight loss. Cardiovascular benefits include improved blood pressure, reduced inflammation markers, and decreased risk of heart disease. These metabolic improvements often occur alongside weight reduction.

Patient satisfaction extends beyond the scale; many report sustained energy, better sleep quality, and improved mental clarity as appetite-driven patterns normalize. PlexusDx's 503A compounded formulations deliver the same active pharmacology as brand-name options while remaining accessible without insurance. The addition of genetic testing helps identify which patients will experience maximal benefit and which may benefit from dual-compound options like GLP-Squared.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How much weight will I lose in the first month of semaglutide?

Most patients lose 2-5 pounds in month one as appetite reduces and dose titration begins. Substantial weight loss accelerates between months 3-6 once your body reaches therapeutic dosing. PlexusDx tracks individual progress and adjusts compounded semaglutide dosing monthly to optimize your outcomes.

Can I maintain weight loss after stopping semaglutide?

Clinical data shows that weight gradually returns if semaglutide is discontinued without sustained lifestyle changes. The medication works best as part of a long-term health strategy combining nutritious eating, movement, and stress management. PlexusDx patients can continue treatment indefinitely at $189/month flat rate across all dosage levels.

Is compounded semaglutide from PlexusDx as effective as brand-name Wegovy?

PlexusDx compounded semaglutide contains the identical active pharmaceutical ingredient prepared by licensed 503A compounding pharmacies. The bioavailability and clinical efficacy match brand formulations. HSA/FSA eligibility and flat monthly pricing ($149 start) make PlexusDx accessible across all 50 states without insurance requirements.

What side effects should I expect with semaglutide?

Nausea, constipation, and mild fatigue occur in early weeks and typically resolve within 2-4 weeks of consistent dosing. Serious adverse events are rare and decrease with slow dose titration. Your PlexusDx provider monitors tolerability monthly and adjusts your compounded dose or formulation (oral vs. injection) if needed.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.